Literature DB >> 7175374

Genetic variation in human apolipoprotein E.

M R Wardell, P A Suckling, E D Janus.   

Abstract

Genetic variation in human apoprotein E was studied using the technique of isoelectric focusing applied to delipidated very low density lipoprotein from 426 Christchurch blood donors and 7 patients with type III hyperlipoproteinemia. Six phenotypes were distinguishable by the relative proportions of the apoprotein E isomers. In the blood donors, observed frequencies for these were: E3/3 = 51.4%; E4/3 = 25.0%; E4/4 = 1.0%; E3/2 - 20.0%; E4/2 = 1.2%; and E2/2 = 1.4%. All seven patients with type III hyperlipoproteinemia exhibited phenotype E2/2. Family studies of apoprotein E variants support a mode of inheritance controlled by three alleles acting at one gene locus. On this basis, the alleles occurred in the blood donor population with frequencies of 0.72 for the epsilon 3 allele, 0.12 for the epsilon 2 allele, and 0.16 for the epsilon 4 allele. The epsilon 2 allele influenced plasma cholesterol. The mean plasma cholesterol in subjects heterozygous for the epsilon 2 allele was 5.32 mmol/l, very significantly less (P less than 0.01) than the mean of 5.84 mmol/l in an age- and sex-matched group of subjects without this allele in their genotype. The mean plasma cholesterol value of 4.92 mmol/l for the five individuals homozygous for the epsilon 2 allele was also significantly less (P less than 0.05) than for age- and sex-matched subjects without the epsilon allele, whose mean was 5.80 mmol/l.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7175374

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.

Authors:  E Boerwinkle; G Utermann
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

2.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Authors:  Dorothy A Kieffer; Valentina Medici
Journal:  Liver Res       Date:  2017-08-16

3.  Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels.

Authors:  M Smit; P de Knijff; M Rosseneu; J Bury; E Klasen; R Frants; L Havekes
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

4.  Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.

Authors:  M R Wardell; S O Brennan; E D Janus; R Fraser; R W Carrell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death.

Authors:  James T Becker; Jeremy J Martinson; Sudhir Penugonda; Lawrence Kingsley; Samantha Molsberry; Sandra Reynolds; Aaron Aronow; Karl Goodkin; Andrew Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

Review 6.  Very low density lipoprotein apolipoprotein B metabolism in humans.

Authors:  T Demant; J Shepherd; C J Packard
Journal:  Klin Wochenschr       Date:  1988-08-15

7.  A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.

Authors:  K H Weisgraber; S C Rall; T L Innerarity; R W Mahley; T Kuusi; C Ehnholm
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  An increased incidence of apolipoprotein E2/E2 and E4/E4 in retinitis pigmentosa.

Authors:  L Huq; T McLachlan; H M Hammer; D Bedford; C J Packard; J Shepherd; C A Converse
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

9.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

10.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

Authors:  C F Sing; J Davignon
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.